We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+18.99%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13.3B
AUM Growth
+$2.87B
(+28%)
Cap. Flow
+$1.1B
Cap. Flow
% of AUM
8.24%
Top 10 Holdings %
Top 10 Hldgs %
20.04%
Holding
2,557
New
285
Increased
1,225
Reduced
862
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$87.9M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$51.9M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$44.1M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$40.8M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$28.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$50.5M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$41.1M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$28.4M |
| 4 |
Pacer Trendpilot US Large Cap ETF
PTLC
|
+$22.6M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$18.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.95% |
| 2 | Consumer Discretionary | 4.49% |
| 3 | Healthcare | 4.46% |
| 4 | Financials | 4.28% |
| 5 | Communication Services | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Enbridge
ENB
$113B
| $7.14M | 0.05% |
234,728
+41,521
| +21% | +$1.28M |
|
327
Allstate
ALL
$66.3B
| $7.11M | 0.05% |
73,275
-9,660
| -12% | -$949K |
|
328
iShares Russell 2000 Value ETF
IWN
$14.6B
| $7.07M | 0.05% |
72,568
+23,805
| +49% | +$2.17M |
|
329
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
| $7.04M | 0.05% |
184,213
+19,679
| +12% | +$735K |
|
330
WisdomTree International MidCap Dividend Fund
DIM
$168M
| $7.04M | 0.05% |
131,479
-33,666
| -20% | -$1.71M |
|
331
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
| $7.03M | 0.05% |
129,921
+61,582
| +90% | +$3.28M |
|
332
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
| $7.03M | 0.05% |
125,560
-2,884
| -2% | -$150K |
|
333
DuPont de Nemours
DD
$19.5B
| $7.03M | 0.05% |
105,420
+57,107
| +118% | +$3.33M |
|
334
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.94B
| $7.02M | 0.05% |
130,533
-92,170
| -41% | -$4.59M |
|
335
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
| $6.99M | 0.05% |
231,428
-78,980
| -25% | -$2.29M |
|
336
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
| $6.94M | 0.05% |
41,457
+13,754
| +50% | +$2.3M |
|
337
Newmont
NEM
$124B
| $6.86M | 0.05% |
111,179
+31,119
| +39% | +$1.84M |
|
338
Tyson Foods
TSN
$19.9B
| $6.86M | 0.05% |
114,947
+67,287
| +141% | +$4.08M |
|
339
Intuitive Surgical
ISRG
$142B
| $6.86M | 0.05% |
36,093
+3,021
| +9% | +$542K |
|
340
L3Harris
LHX
$53.3B
| $6.85M | 0.05% |
40,356
+1,911
| +5% | +$359K |
|
341
Bio-Techne
TECH
$11.2B
| $6.78M | 0.05% |
102,728
-640
| -0.6% | -$38.3K |
|
342
Truist Financial
TFC
$63.9B
| $6.78M | 0.05% |
180,527
+4,133
| +2% | +$149K |
|
343
Illinois Tool Works
ITW
$83.5B
| $6.74M | 0.05% |
38,535
+3,836
| +11% | +$626K |
|
344
Becton Dickinson
BDX
$49.4B
| $6.73M | 0.05% |
28,835
+1,121
| +4% | +$270K |
|
345
Trade Desk
TTD
$6.37B
| $6.68M | 0.05% |
164,410
+61,430
| +60% | +$1.85M |
|
346
Zoom
ZM
$31.1B
| $6.68M | 0.05% |
26,343
-2,248
| -8% | -$404K |
|
347
Vanguard FTSE All-World ex-US ETF
VEU
$70B
| $6.67M | 0.05% |
140,075
+8,659
| +7% | +$388K |
|
348
Crown Castle
CCI
$31.3B
| $6.65M | 0.05% |
39,745
+1,790
| +5% | +$288K |
|
349
ARK Genomic Revolution ETF
ARKG
$1.79B
| $6.62M | 0.05% |
126,987
-2,785
| -2% | -$119K |
|
350
ServiceNow
NOW
$132B
| $6.6M | 0.05% |
81,495
+6,515
| +9% | +$460K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Cambridge Investment Research Advisors held 2,557 positions worth $13.3B, up 28% from $10.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $1.1B of net new capital in Q2 2020, opening 285 new positions and adding to 1,225 existing holdings. Its largest new stake was FS KKR Capital Corp. II: 1,991,449 shares worth $25.7M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $50.5M trimmed.
- Cambridge Investment Research Advisors's largest Q2 2020 buy was FS KKR Capital Corp. II: 1,991,449 shares worth $25.7M.
- Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q2 2020, an estimated $87.9M increase.
- Cambridge Investment Research Advisors's biggest Q2 2020 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $50.5M.
- Cambridge Investment Research Advisors fully exited Raytheon Company in Q2 2020, selling an estimated $7.24M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $13.3B portfolio in Q2 2020.
- Cambridge Investment Research Advisors opened 285 new positions and closed 103 in Q2 2020.
- Cambridge Investment Research Advisors's portfolio value rose 28% quarter-over-quarter to $13.3B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.